A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) Respirator Solution. 1997

C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
Division of Respiratory Medicine, Montreal Children's Hospital-McGill Research Institute, Quebec, Canada.

The two most common albuterol preparations used for nebulization are: (1) Ventolin (albuterol) respirator solution (Glaxo Canada Inc; Montreal, Canada) of which 2.5 mg (0.5 mL) is diluted with 2 mL of normal saline solution, and (2) the preservative-free, prediluted Ventolin (albuterol) Nebules PF (Glaxo) (2.5 mg/2.5 mL). The two preparations were compared using both a Hudson 1720 "T" up-draft Neb-U-Mist jet nebulizer and a Hudson 1730 "T" up-draft Neb-U-Mist II jet nebulizer (Hudson; Temecula, Calif), which were driven by a compressor (Pulmo-Aide; Devilbiss; Somerset, Pa) and by dry compressed air at 6 and 8 L/min. Particle size distribution was measured with a particle sizer (Malvern 2600; Malvern Instruments; Malvern, UK) and drug output for the nebulizer was calculated from the differences in predrug and postdrug volume and concentration. Drug availability was defined as the amount of drug carried in particles less than 5 microns in diameter. Drug availability was greater with the albuterol respiratory solution, due to the surface activity of the preservative benzalkonium chloride, for both nebulizers but particularly for the 1720. Differences in drug availability between nebulizers exceeded fourfold depending on the preparation, the nebulizer, and the nebulizing flow. These differences could not have been predicted from the manufacturer's specifications. The results suggest that prediction of drug availability must be based on measurements with the specific preparation and the specific nebulizer used.

UI MeSH Term Description Entries
D009330 Nebulizers and Vaporizers Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. Atomizers,Inhalation Devices,Inhalators,Inhalers,Vaporizers,Nebulizers,Vaporizers and Nebulizers,Atomizer,Device, Inhalation,Devices, Inhalation,Inhalation Device,Inhalator,Inhaler,Nebulizer,Vaporizer
D011310 Preservatives, Pharmaceutical Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include ANTI-BACTERIAL AGENTS and antioxidants. Pharmaceutic Aids (Preservatives),Pharmaceutic Preservative,Pharmaceutic Preservatives,Pharmaceutical Preservative,Pharmaceutical Preservatives,Preservative, Pharmaceutic,Preservative, Pharmaceutical,Preservatives, Pharmaceutic
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000420 Albuterol A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. Salbutamol,2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol,Albuterol Sulfate,Proventil,Sultanol,Ventolin
D001548 Benzalkonium Compounds A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics. Benzalkonium,Benzalkonium Chloride,Alkyldimethylbenzylammonium Chloride,Asepsol,BTC-2125,Drapolene,Germex,Osvan,Zephiran,BTC 2125,BTC2125,Chloride, Alkyldimethylbenzylammonium,Chloride, Benzalkonium,Compounds, Benzalkonium
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
March 2000, Chest,
C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
January 1993, Boletin de la Asociacion Medica de Puerto Rico,
C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
January 2018, PloS one,
C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
September 2004, Clinical pediatrics,
C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
August 2017, Journal of aerosol medicine and pulmonary drug delivery,
C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
December 2001, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
June 2020, Pharmaceutics,
C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
April 1978, Praxis und Klinik der Pneumologie,
C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
April 1982, The Journal of the American Osteopathic Association,
C F MacNeish, and D Meisner, and R Thibert, and S Kelemen, and E B Vadas, and A L Coates
January 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine,
Copied contents to your clipboard!